Neurocrine Biosciences, Inc. (LON: 0K6R)

Neurocrine Biosciences Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jan 31, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	12,366	10,163	9,530	5,967	6,559	7,474
Market Cap Growth	-3.58%	6.65%	59.70%	-9.03%	-12.24%	47.11%
Enterprise Value	11,609	9,518	9,101	5,736	6,246	7,335
Last Close Price	123.00	104.04	98.59	63.33	70.46	80.53
PE Ratio	42.95	51.84	74.32	90.18	21.99	267.54
PS Ratio	5.19	6.86	7.71	7.13	8.56	12.56
PB Ratio	4.28	5.80	6.72	5.88	7.95	15.54
P/TBV Ratio	4.34	5.91	6.90	5.88	7.95	15.54
P/FCF Ratio	26.44	35.80	35.56	34.66	41.15	74.82
P/OCF Ratio	24.42	33.20	33.83	31.50	39.19	67.34
EV/Sales Ratio	6.43	6.42	7.37	6.85	8.15	12.33
EV/EBITDA Ratio	21.86	29.14	41.44	35.51	25.37	41.52
EV/EBIT Ratio	23.96	30.71	44.04	37.37	26.04	42.87
EV/FCF Ratio	35.35	33.53	33.96	33.32	39.19	73.43
Debt / Equity Ratio	0.11	0.21	0.15	0.32	0.37	0.78
Debt / EBITDA Ratio	0.43	1.06	0.94	1.88	1.19	2.05
Debt / FCF Ratio	0.65	1.27	0.81	1.89	1.89	3.75
Asset Turnover	0.70	0.67	0.67	0.60	0.69	0.69
Inventory Turnover	19.20	16.48	14.85	11.71	12.59	14.73
Quick Ratio	3.98	2.25	2.49	3.65	5.14	1.41
Current Ratio	4.37	2.45	2.70	3.96	5.45	1.47
Return on Equity (ROE)	16.35%	12.68%	10.03%	7.17%	46.20%	6.62%
Return on Assets (ROA)	11.79%	8.78%	7.01%	6.82%	13.46%	12.32%
Return on Capital (ROIC)	14.26%	10.58%	8.22%	7.75%	15.33%	14.15%
Earnings Yield	2.33%	1.93%	1.35%	1.11%	4.55%	0.37%
FCF Yield	2.66%	2.79%	2.81%	2.88%	2.43%	1.34%
Buyback Yield / Dilution	-2.91%	-2.12%	-1.02%	-0.10%	-2.19%	-0.31%
Total Shareholder Return	-2.91%	-2.12%	-1.02%	-0.10%	-2.19%	-0.31%

Source: S&P Capital IQ. Standard template. Financial Sources.